TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion of Subjects With Minimal Residual Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of self-reported osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of the score on the Insomnia Severity Index (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Efficacy of conjugated estrogen in treating atrophic vaginitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Clonal evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARDS development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety and tolerability of BMS-582949
Endpoint domain: Adverse events/effects
Primary endpoint: Child dental caries incidence and increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability and validity of Multidimensional Fatigue Inventory
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reliability and validity of Fatigue Severity Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Time taken to reach the maximum observed plasma concentration (Tmax) of ertugliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Intensive Computerized Brain Training (ICBT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tolerability of Intensive Computerized Brain Training (ICBT)
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of Intensive Computerized Brain Training (ICBT)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in gait speed from baseline to 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in balance from baseline to 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fear of falling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived stress, anxiety and depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in orthostatic cardiovascular responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage days abstinent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Residual cancer burden (RCB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: absolute FEV1 increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Presence of IIM diagnosed by muscle biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal and neonate/infant testosterone and cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of mother-infant interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infant cognitive/motor/language development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliable Change Index (RCI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Microbiome variety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relationship functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Duration of Lung Ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Impressions at Final Visit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: gait cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ground reaction forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of Local and General Solicited Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited Adverse Events (UAE)
Endpoint domain: Adverse events/effects
Primary endpoint: mean thickness of formed dentinal bridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphology of formed dentinal bridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensity of pulp inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: registration errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: planning time for the post-implant plan
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: elimination of the CT scan
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum tolerated dose of clofarabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Everyday Memory Questionnaire-Revised (EMQ-R)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Memory Controllability Inventory (MCI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Multifactorial Memory Questionnaire (MMQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brief Test of Adult Cognition by Telephone with Stop-and-Go Switch Task (BTACT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: FActS-HF 15 total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acoustic Radiation Force Impulse (ARFI) imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard uptake values (SUV) of volumes of interest (VOI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin-stimulated AKT Phosphorylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Parent-rated social skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Child-rated social skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in the Short Physical Performance Battery (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-associated Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Metacognitive bias on the episodic predictive judgment task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Metacognitive accuracy on the episodic predictive judgment task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient care satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Insomnia Severity Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Success rates of passing a peanut DBPCFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rates of passing a DBPCFC to peanut and at least one other FA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rates of passing a DBPCFC to peanut and two other FAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Supination Strength Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Regional ventilation heterogeneity percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Any Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Modified Psoriatic Arthritis Response criteria (PsARC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in total International Prostate Symptom Score (I-PSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in lesion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: brain inflammatory level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: extent of clinical improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Short Form (SF)-12 PCS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants Who Developed RSV LRTI
Endpoint domain: Adverse events/effects
Primary endpoint: Bone Speed of Sound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foley Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: EP3 receptor mRNA levels in cervical tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anisotropy in hippocampal formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in body weight 10 weeks post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in body weight 26 weeks post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Determining dose limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Confirmed Objective Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of I/R injury markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miRNA expression profile in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival Motor Neuron (SMN) Messenger Ribonucleic Acid (mRNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival Motor Neuron (SMN) Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) on Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheal and erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Banff score for fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: glomerular filtration rate assessed by creatinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: glomerular filtration rate assessed by insulin clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in Edinburgh Postnatal Depression Scale (EPDS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in craving
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxytocin/cortisol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean Change in Delayed Recall Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Confirmed Best Objective Tumor Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of PCR-confirmed Influenza Infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cognitive Assessment Screening Instrument (CASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clock Drawing Test-Drawing Part (CDT-D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Annualized LC-FAOD Major Clinical Events (MCEs) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) or Serious TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in gene expression of PPAR-gamma coactivator 1-alpha target genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in biomechanical movement patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Velocity of weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of comfortable days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline in work capacity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in observed skin wrinkling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline in Symptom Checklist 90-R (SCL90-R)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of III/IV neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: NT-proBNP serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Asthma Control Test Score variation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complications after implant removal
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the plasma concentration-time curve (AUC0-12) of darunavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Brain distribution of AZD1390
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of correct central venous catheter position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Treatment-related Adverse Events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Respiratory Chain Enzyme Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of heart function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Positive predictive value of alerts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Monthly Rate of Decline in ALSFRS-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Status of Tissue Iron Store
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Status of Cellular Iron Deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fluorescence of responding cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in percentage of responding cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: home-based cognitive monitoring score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Successful Intercourse
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: postoperative narcotic pain medication requirements
Endpoint domain: Adverse events/effects
Primary endpoint: length of time to tolerating full feeds prior to discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: AUC(0-t) of ibuprofen and pseudoephedrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum serum concentration of ibuprofen and pseudoephedrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects current on individual preventive services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of subjects current on all indicated preventive services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean score for quality of clinician communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bleeding time at donor site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in coronary Flow Reserve (PET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serious Adverse Device Effect (SADE) - free rate for Eluna pacemaker family
Endpoint domain: Adverse events/effects
Primary endpoint: Serious Adverse Device Effect (SADE) - free rate for Sentus BP lead
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Severity of Diarrhea Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Complete clearance of the treatment-targeted great toenail
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Trough Sitting Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Behavioural disorder outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional disorder outcome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in knowledge score of LDKT
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Behavioural Symptoms (NPI - 12 Items Version Total Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognition (SIB Total Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic performance of myelin-TRAP assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of abnormal glucose intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LARC Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: STI Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Times Having Sex Without a Condom
Endpoint domain: Life impact
Endpoint subdomain: Risk-related behavior
Primary endpoint: Intact survival without RDS and/or severe ICH
Endpoint domain: Mortality/survival
Primary endpoint: Specificity Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment rate of pregnant mothers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Thought Language Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to remission of positive symptoms of psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to remission of negative symptoms of psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End of treatment response rate (HCV RNA:Neg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: AUC of BAY1817080 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed concentration of BAY1817080 in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of total radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific Morbidity Index Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nutritional Quality of Food Purchases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in erectile function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: overall intraoral cold sensitivity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: 6-month-PFS
Endpoint domain: Mortality/survival
Primary endpoint: Hepato-Renal Index (HRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross Motor Proficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in mean inflammatory lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Absolute change in mean non-inflammatory lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percent of subjects achieving at least a two-grade reduction in Evaluator's Global Severity Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: improvement in vaginal dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in overall QOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in trough Forced Expiratory Volume1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of Acute grade 2 or higher toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of chronic Toxicity grade 2 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Ipsilateral local tumor recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Culprit lesion morphologies assessed by OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Assessed Ocular Itching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes